A Bioelectronic Medicine Company
advancing the treatment of autoimmune diseases.
Boomerang Medical is a women-led bioelectronic medicine company on a mission to disrupt the treatment of autoimmune diseases. The company is developing a bioelectric neuromodulation technology, which has been granted Breakthrough Device Designation by the FDA for the treatment of Crohn's disease and ulcerative colitis. The technology is currently being evaluated in an FDA-approved clinical trial at leading IBD centers in the US.
Inflammatory Bowel Disease (IBD) is one of the most debilitating autoimmune diseases, affecting millions globally. Living with Crohn's disease or ulcerative colitis impacts not just physical health, but also work, relationships, and well-being. Current treatments include medications and surgery, but the complexity of the condition means that there is always room for innovative approaches.
What if the next big leap in managing IBD is already hardwired into our bodies? That's the question propelling our focus on neuromodulation, a promising frontier in bioelectronic medicine.
Boomerang Medical is dedicated to promoting IBD awareness and education. We are proud to be a member of the Crohn’s & Colitis Foundation's Corporate Circle.
Boomerang Medical is headquartered in the heart of Silicon Valley on the campus of El Camino Hospital in Mountain View, California. We are proud to be a Company–In-Residence at the prestigious Fogarty Innovation incubator–the only healthcare-focused incubator of its kind in the US–giving us access to the brightest minds and expertise in the medical technology industry.
Does Inflammatory Bowel Disease disrupt your daily life?
Researchers in the BOOM-IBD Clinical Trial are exploring whether nerve stimulation, a therapy already approved by the FDA to treat other conditions, can be effective for treating Inflammatory Bowel Disease.
Meet the Team
President & Chief Executive Officer
For 30 years, Heather has pursued her passion for solving the puzzle of bringing new medical technologies from bench to bedside. She is the former President of PQ Bypass, which was acquired in 2021 in one of the highest value vascular device transactions in recent history.
Chief Operating Officer
Pharoah Garma, MEng
Pharoah is a former FDA Senior Lead Reviewer and operational leader with a 20-year track record of leading high-performing teams to execute speed-to-patient strategies. She is a recognized expert in Class III medical devices and device/drug combination products.
Co-Founder, Chief Innovation + Technology Officer
David Miller, MEng
David is an innovator and entrepreneur, holding more than 50 patents spanning diverse technologies and clinical applications. With over 20 years of experience, David has co-founded multiple companies, is a Stanford BioDesign Fellow, and was previously a Distinguished Scientist and Technical Fellow at Medtronic.
Vice President, Clinical Affairs
Colleen has a deep understanding of clinical research and regulatory affairs within the medical device industry. She holds 20+ years of experience conducting 25 clinical trials and a proven track record of leading Class III medical device trials from inception to FDA approval.
Vice President, Therapy Development
Lucas has 20+ years of experience leveraging his passion for patient care, HCP training and entrepreneurship to advance Class III medical device innovation for companies such as Johnson & Johnson and Abbott. Lucas began his career in the medical field in patient care as a radiation technologist.
Senior Director, Clinical + Field Operations
Malea D'Amico, CCRA, CCRP
Malea has spent 21 years on the front lines of clinical research in over 70 medtech and biotech clinical trials. An expert in clinical study quality assurance, her experience crosses all phases clinical trials including benchwork, QA, monitoring, field support and patient outreach.
Project Manager, Clinical + Regulatory Affairs
Grace is a Regulatory expert with 22 years of experience in implantable medical devices. From Design Dossiers and Technical Files to breakthrough devices, her experience with FDA, notified bodies, and international agencies covers the full product lifecycle.
Communications + Field Operations Associate
Braden is a strategic communicator who enjoys creating actionable marketing and communications solutions to produce measurable results for early-stage companies. Previously, Braden was on the portfolio services team at Norwest Venture Partners, providing marketing and networking support to 175+ companies.
Board of Directors + Advisors
Boomerang Medical is proud to be a portfolio company of
Company-In-Residence at Fogarty Innovation.
President & CEO
Chief Executive Officer
Tom Shehab, MD
Chief Financial Officer
Hatteras Venture Partners
Director of Innovation Acceleration
Boomerang Medical in the News
Fogarty Innovation | Nov 22, 2022
At Fogarty Innovation we are fortunate to have a front-row seat as our companies pioneer innovations that solve meaningful problems in patient care.
San Francisco Business Times | Mar 3, 2023
We talked to the CEOs of some of the Bay Area's most promising life science startups to find
Medical Device Network | Apr 18, 2023
The trial will assess the use of nerve stimulation as a potential treatment for Crohn’s disease and ulcerative colitis.